www.medpagetoday.com SAN ANTONIO — Results from the largest randomized trial to date comparing angioplasty and carotid artery stenting to endarterectomy for treatment of symptomatic and asymptomatic carotid stenosis suggest there are no significant differences between the two treatments. Those results from the long-awaited CREST trial were reported at a late-breaking clinical trials session at the American Stroke Association’s International Stroke Conference here and provide a different perspective from the ISCC trial findings reported yesterday online in Lancet Neurology. In this MedPage Today InFocus™ report, Ralph Sacco, MD, of the University of Miami, reviews the CREST findings and their clinical implications. Sacco, who is president-elect of the American Heart Association, told executive editor Peggy Peck that the CREST results are not the final word on the two techniques, but the results are reassuring for clinicians who support carotid stenting.
Archive
Posts Tagged ‘Stenting’
Two common treatments for carotid artery stenosis each carry their own risks of adverse events, according to a comparative study published in the latest issue of the New England Journal of Medicine. Here is some information about carotid artery stenosis and its treatment: • The condition refers to a narrowing in the carotid arteries, which are located in the neck and are the primary source of blood for the brain • It can be treated with stenting, in which a small metal tube is placed in the artery to hold open the narrowed area • It can also be treated with endarterectomy, in which the plaque that is causing the narrowing is removed Researchers from the Mayo Clinic in Jacksonville randomly assigned over 2500 individuals with carotid artery stenosis to be treated with either stenting or endarterectomy. The investigators followed-up the patients to see who experienced adverse events known to be associated with these procedures, including stroke, heart attack, and death. Importantly, both procedures were generally found to be safe and effective. The overall estimated risk of stroke, heart attack, or death during the four years following each procedure was similar for both groups of patients. Looking at the risk for individual adverse events on their own, however, revealed that stented patients were more likely to experience a stroke while those who underwent endarterectomy were more likely to experience a heart attack. These differences were primarily apparent during the …
In this short video, Dr. Brajesh Lal discusses some of the exciting changes occurring in the management of vascular disease. As a specialist in this field, Dr. Lal provides his insights and opinions about the new treatment options now available to vascular disease patients and what these new approaches mean for future patient outcomes. Dr. Lal addresses the benefits of combining different approaches to vascular disease management to formulate the most optimal method of treatment for each individual patient. He emphasizes the importance of receiving treatment from a vascular specialist who is able to offer a variety of treatment options — namely medical management, stenting and surgery — to ensure that patients receive the most unbiased medical opinion available and the best combined management possible. Related Links: Dr. Brajesh Lal www.umm.edu Maryland Vascular Center www.umm.edu Vascular Disease Screening www.umm.edu Podcast: Endarterectomy vs. Stent www.umm.edu Physicians and Staff www.umm.edu Distributed by Tubemogul.
View this Lecture for FREE by signing up at www.prolibraries.com Viewany number of our other 28000 sessions from over 280 conferences by going to www.prolibraries.com Speaker(s) Tony S. Das, MD Klaus D. Mathias, MD Carotid Artery Disease and Stenting – International Symposium on Endovascular Therapy ISET 2010 Don’t miss the meeting that offers a truly global approach to cardiovascular disease.ISET is again redefining endovascular therapy. ISET recognizes that interventionists who treat peripheral and coronary disease work with similar devices and techniques. The ISET program takes an integrated approach that emphasizes subject matter of shared interest. Join us for a multidisciplinary meeting that recognizes the value of bringing together diverse specialists with a common goal. It’s a new dynamic for a new era. Regency Ballroom 1 459076120202b5ed67f862def10d8fbf
Stroke is the third most common cause of death in the United States and carotid artery disease is the most common cause of stroke. In recent years, carotid stenting has become an alternative for patients who are high risks for surgery. Carotid stenting is a procedure in which a stent is delivered and expanded inside the carotid artery to increase blood flow in the area blocked by plaque.
Cedars-Sinai Neurovascular Center’s clinical trial of minimally invasive stenting procedure for TIA
Individuals between 30 and 80 years of age, who have had a transient ischemic attack (TIA) or non-severe stroke within the past 30 days, and who cannot be treated surgically, may be eligible to participate in a Phase III clinical trial of a minimally invasive stenting procedure at the Cedars-Sinai Neurovascular Center. The study will focus specifically on patients who have had an intracranial …
Read more on News-Medical-Net
Carotid artery stenting versus surgery: adequate comparisons?
A moratorium on carotid artery stenting (CAS) has been recently proposed. 1 Current randomised evidence supports the notion that carotid endarterectomy (CEA) is better than CAS. A meta-analysis of the randomised trials compared the two strategies 2 and included data from the recent International Carotid Stenting Study (ICSS).
Read more on Lancet